Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesPostmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999–2002
Current Medical Research and Opinion, 06/23/09
Bottone FG et al. - It can be postulated that in addition to the risk of heart attack and stroke, rofecoxib users were at increased risk of hemorrhage, in addition to other thrombotic and embolic adverse events, which was exacerbated in those taking blood thinners or NSAIDs.
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
Journal of the National Cancer Institute, 12/15/09
A Holistic Approach to Androgen Deprivation Therapy: Treating the Cancer without Hurting the Patient
Urologia Internationalis, 12/14/09
Spontaneous reporting of adverse drug reactions at a department of Internal Medicine
Central European Journal of Medicine, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor